Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women
- 4 July 2008
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 26 (29-30), 3608-3616
- https://doi.org/10.1016/j.vaccine.2008.04.074
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-upBritish Journal of Cancer, 2006
- Worldwide Human Papillomavirus Etiology of Cervical Adenocarcinoma and Its Cofactors: Implications for Screening and PreventionJNCI Journal of the National Cancer Institute, 2006
- Optimization and Validation of a Multiplexed Luminex Assay To Quantify Antibodies to Neutralizing Epitopes on Human Papillomaviruses 6, 11, 16, and 18Clinical and Vaccine Immunology, 2005
- Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccineVaccine, 2005
- Against which human papillomavirus types shall we vaccinate and screen? the international perspectiveInternational Journal of Cancer, 2004
- Comparison of Ophthalmic Sponges for Measurements of Immune Markers from Cervical SecretionsClinical and Vaccine Immunology, 2004
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003
- Simultaneous Quantitation of Antibodies to Neutralizing Epitopes on Virus-Like Particles for Human Papillomavirus Types 6, 11, 16, and 18 by a Multiplexed Luminex AssayClinical and Vaccine Immunology, 2003
- Evaluation of Seroreactivity to Human Papillomavirus Type 16 Virus-like Particles in an Incident Case-Control Study of Cervical NeoplasiaThe Journal of Infectious Diseases, 1995
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995